Axonics®, Inc. (NASDAQ: AXNX)
Axonics is a medical device company, headquartered in Irvine, the medical technology hub of Southern California.
Axonics aspires to be the global leader in incontinence therapies by providing customer-centric solutions to treat urinary and bowel dysfunction and improve quality of life for patients and their families.
Life-Changing Solutions for people with incontinence
The Axonics System is a clinically proven, long-lasting solution for people suffering with overactive bladder, fecal incontinence and urinary retention. Bulkamid® is an innovative bulking agent indicated to treat women suffering with stress urinary incontinence (SUI).
The Axonics System
Sacral neuromodulation is a guideline recommended therapy which restores normal control of the bladder and bowel, treating overactive bladder, urinary retention, and fecal incontinence.
The Axonics System features a miniatured, long-lived, rechargeable neurostimulator approved to provide therapy for at least 15 years, reducing the need for frequent device replacement surgeries.
The Bulkamid System
Bulkamid is a unique bulking agent for the treatment of female stress urinary incontinence. In contrast to particulate bulking agents, Bulkamid is a non-particulate hydrogel designed to deliver stable, long-lasting urethral bulking.
The Axonics leadership team is an experienced and dedicated group working diligently to achieve our mission. Meet the executives who provide our strategic vision and direct our operations.
Our people are our greatest strength. At Axonics, we look for individuals who seek a challenging, growth-oriented, and friendly environment. Interested in joining Axonics? Meet our team and see what it’s like to be part of the Axonics family.
Our policy is to continuously improve the quality, compliance, safety, and effectiveness of our processes, products, and workforce in order to meet or exceed the requirements of our customers, regulatory bodies, and our own Quality System.
We are here to help answer any questions you may have about Axonics Therapy.